Hydrochlorothiazide: Not Recommended For First-Line Therapy In Hypertension[caption id="attachment_832" align="alignnone" width="120" caption="Franz Messerli"][/caption]New York cardiologist Franz Messerli explains to Peter Goodwin why he doesn't prescribe the popular
Central Pressure And New Goals: Should Be Hypertension Therapy Priorities[caption id="attachment_844" align="alignnone" width="120" caption="Björn Dahlöf"][/caption]A fundamental change in the way hypertension is measured, and studies to identify evidence-based blood
Microalbuminuria: Undervalued As A Risk Assessment Tool[caption id="attachment_835" align="alignnone" width="120" caption="Hermann Haller"][/caption]Hermann Haller tells Peter Goodwin about the significant health risks—including for renal disease, myocardial infarction
Post a comment